Filing Details

Accession Number:
0000904454-17-000137
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-08 18:40:22
Reporting Period:
2017-02-06
Filing Date:
2017-02-08
Accepted Time:
2017-02-08 18:40:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178711 Paratek Pharmaceuticals Inc. PRTK Pharmaceutical Preparations (2834) 330960223
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1628880 W. Douglas Pagan C/o Paratek Pharmaceuticals, Inc.
75 Park Plaza, 4Th Floor
Boston MA 02116
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-02-06 17 $15.20 58,983 No 4 S Direct
Common Stock Disposition 2017-02-06 732 $15.15 58,251 No 4 S Direct
Common Stock Disposition 2017-02-06 1,428 $15.10 56,823 No 4 S Direct
Common Stock Disposition 2017-02-06 17 $15.08 56,806 No 4 S Direct
Common Stock Disposition 2017-02-06 1,186 $15.05 55,620 No 4 S Direct
Common Stock Disposition 2017-02-06 25 $15.09 55,595 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Sale of shares to cover personal income tax obligations upon vesting of restricted stock unit award, pursuant to Rule 10b5-1 trading plan.